{"id":"NCT00153166","sponsor":"Brigham and Women's Hospital","briefTitle":"ARREST PAD (Peripheral Arterial Disease)","officialTitle":"The Contribution of Inflammation and Insulin Resistance to Intermittent Claudication","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2004-01","primaryCompletion":"2010-11","completion":"2011-12","firstPosted":"2005-09-12","resultsPosted":"2014-09-30","lastUpdate":"2014-09-30"},"enrollment":76,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Arterial Occlusive Disease","Intermittent Claudication","Insulin Resistance"],"interventions":[{"type":"DRUG","name":"atorvastatin and pioglitazone","otherNames":["atorvastatin: lipitor","pioglitazone: actos"]},{"type":"DRUG","name":"atorvastatin/placebo","otherNames":["atorvastatin: lipitor"]},{"type":"DRUG","name":"pioglitazone/placebo","otherNames":["pioglitazone: actos"]},{"type":"DRUG","name":"placebo/placebo","otherNames":[]}],"arms":[{"label":"Patients with PAD (Including diabetics)","type":"EXPERIMENTAL"},{"label":"PAD (Excluding Diabetics)","type":"ACTIVE_COMPARATOR"},{"label":"Healthy Controls","type":"ACTIVE_COMPARATOR"}],"summary":"This trial will test the hypothesis that inflammation and insulin resistance contribute to reduced walking distance in subjects with intermittent claudication by impairing vascular reactivity and skeletal muscle metabolic function.","primaryOutcome":{"measure":"Lower Extremity Skeletal Muscle Glucose Uptake","timeFrame":"60 minutes","effectByArm":[{"arm":"Healthy Controls","deltaMin":62.9,"sd":21},{"arm":"Patients With PAD","deltaMin":48.6,"sd":15},{"arm":"PAD (Excluding Diabetes)","deltaMin":49.5,"sd":3.1}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":11},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["25095746"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":19},"commonTop":[]}}